(813) 345-4044 1767 S. Kings Ave., Brandon, FL
(813) 345-4044 | info@floridaaesthetics.com | Mon–Tue & Thu–Fri: 8am–5pm  ·  Wed: 10am–7pm | 1767 S. Kings Ave., Brandon, FL 33511
Weight Loss Semaglutide at Florida Aesthetics and Wellness Brandon FL

Weight Loss · GLP-1 Therapy · Brandon, FL

Semaglutide Weight Loss in Brandon, FL

GLP-1 Weight Loss Program, FDA-approved for chronic weight management. Clinical trials show average 15% body weight reduction, without surgery.

Book a Free Consultation Call (813) 345-4044
FDA-Approved
for weight management
15% Avg
body weight reduction
Weekly Injection
Medically Supervised
About This Treatment

What is semaglutide and how does it cause weight loss?

Reviewed by our board-certified anti-aging specialists. Medically supervised since 2006.

Semaglutide (brand names Ozempic® and Wegovy®) is an FDA-approved GLP-1 receptor agonist that directly reduces appetite, slows gastric emptying, and improves insulin sensitivity.

Unlike older weight loss medications that worked through stimulants or willpower, semaglutide works at the neurological level, activating GLP-1 receptors in the brain that regulate hunger and satiety. Patients consistently report significant reduction in appetite, reduced food "noise," and feeling full faster. In the STEP clinical trial, patients lost an average of 15% of body weight over 68 weeks. At Florida Aesthetics and Wellness, all semaglutide programs are medically supervised, with weekly check-ins to monitor progress and adjust dosing.

What does semaglutide treat?

  • Overweight (BMI ≥27 with weight-related condition)
  • Obesity (BMI ≥30)
  • Insulin resistance and pre-diabetes
  • Metabolic syndrome
  • Weight regain after previous weight loss
  • Diet-resistant weight

Why patients choose Florida Aesthetics and Wellness

  • Provider-prescribed and supervised
  • Weekly dosing with gradual titration to minimize side effects
  • Weekly progress monitoring
  • Combines with nutritional guidance
  • Medical-grade program, not a telehealth mill

Quick Facts

  • MedicationSemaglutide (GLP-1 agonist)
  • FDA approvedYes, for weight management
  • AdministrationWeekly subcutaneous injection
  • Average weight loss15% over 68 weeks
  • MonitoringWeekly check-ins
  • ConsultationRequired before prescribing
Medically supervised weight loss results at Florida Aesthetics and Wellness Brandon FL
What to Expect

What to expect on your semaglutide journey

1
Medical evaluation
Your provider reviews your health history, current medications, and weight loss goals. Lab work screens for contraindications. A personalized dosing schedule is created.
2
Starting your program
You begin at a low dose to minimize nausea and GI side effects. Most patients tolerate the medication well after the first 2–4 weeks as the body adjusts.
3
Titration phase (weeks 4–16)
Dosing is gradually increased every 4 weeks toward your therapeutic target. You'll notice progressive reduction in appetite and cravings. Most patients begin losing 1–2 lbs per week.
4
Maintenance and monitoring
Weekly in-clinic check-ins track your progress, adjust dosing if needed, and provide ongoing support. We also discuss lifestyle habits, nutrition, and exercise to optimize and sustain results.
Common Questions

Semaglutide Weight Loss, Frequently Asked Questions

Clinical trials (STEP 1–5) show average weight loss of 15% of body weight over 68 weeks, with some patients losing 20%+ when combined with lifestyle modifications. Individual results vary based on starting weight, adherence, diet, and activity level.
The most common side effects are GI-related: nausea, constipation, and reduced appetite. These typically improve after the first 4–8 weeks and are minimized by slow dose titration. Rare but serious side effects include pancreatitis and gallbladder issues, your provider screens for these risks before prescribing.
Weight regain typically occurs after stopping GLP-1 medications. Most patients continue treatment indefinitely or transition to a maintenance strategy. We work with you on a long-term plan.
Yes, semaglutide is the active ingredient in both Ozempic® (approved for type 2 diabetes) and Wegovy® (approved for weight management). The doses differ. At Florida Aesthetics and Wellness, we prescribe the weight management protocol.
Yes, semaglutide pairs well with B12/MIC injections (for energy and metabolism), body composition analysis (to track fat vs. muscle loss), and CoolSculpting (for stubborn fat remaining after weight loss).
Most patients come in weekly. The visit is both your injection and your check-in, so your dose, your progress, and any side effects are reviewed in person as you go. Patients who prefer to self-inject at home can be approved for that by our board-certified anti-aging specialist and come in monthly instead. In both cases your dosing and titration are approved by your provider, not set automatically.
Often Paired With

Treatments that complement Semaglutide

Most patients benefit from at least one complementary treatment for a more complete result.

Aesthetics

Noticing Facial Changes?

Rapid weight loss can deflate the face and loosen skin. See how we restore volume and firmness naturally.

Restore your look →
Weight Loss

Tirzepatide

The dual GIP/GLP-1 agonist showing up to 21% weight loss, for patients seeking maximum results.

Explore tirzepatide →
Weight Loss

B12/MIC Injections

Weekly vitamin and lipotropic injections to boost energy and support fat metabolism during your program.

Explore B12/MIC injections →
Weight Loss

Contrave® (Oral Option)

For patients who prefer an oral medication, Contrave combines naltrexone and bupropion to reduce hunger and food cravings through brain reward pathways.

Learn more about Contrave →
Body Contouring

Body Composition Analysis

Track fat vs. muscle loss with precision, ensure you're losing fat, not muscle, during your program.

Explore body composition →

Curious about cost? Pricing depends on your specific treatment plan, which we map out at your consultation. The treatment you’re interested in might be on sale this month, so see our pricing page for current rates and check this month’s specials.

View Pricing This Month’s Specials

Clinical References

  1. Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989-1002. Mean body weight change of −14.9% at week 68 (STEP 1).
  2. Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022;387(3):205-216. Mean body weight reduction of 15.0%, 19.5% and 20.9% at 72 weeks for the 5 mg, 10 mg and 15 mg doses (SURMOUNT-1).

Trial results reflect study populations under clinical supervision alongside lifestyle intervention. Individual results vary.

Ready to Book?

Start with a complimentary consultation, no obligation

Our medical provider will evaluate your health history and determine if semaglutide is appropriate for you. Schedule your complimentary consultation.

Book a Free Consultation See This Month's Specials Call (813) 345-4044